Effects of long-term phenytoin treatment on brain weight and zinc and copper metabolism in rats.

R Palm, G Hallmans, G Wahlström
{"title":"Effects of long-term phenytoin treatment on brain weight and zinc and copper metabolism in rats.","authors":"R Palm,&nbsp;G Hallmans,&nbsp;G Wahlström","doi":"10.1007/BF03160125","DOIUrl":null,"url":null,"abstract":"<p><p>The effects of phenytoin (PHT) treatment on brain weights and the zinc (Zn) and copper (Cu) concentrations in liver, kidney, and five parts of the brain have been studied in rats. After 32 wk of treatment (daily doses 72-88 mg/kg body weight), significantly reduced brain weights were found in rats sacrificed during treatment, but not in those sacrificed after 14 d of abstinence. The weight reduction mainly seemed to affect cortex, but cerebellum was also influenced. The PHT treatment during 18 wk did not significantly reduce the brain weights. At the end of treatment, significantly increased serum Cu concentrations were found, as well as decreased Zn levels in the liver and low Cu levels in the kidney. No large alterations were found in the trace element concentrations of different brain regions. The PHT treatment for 32 wk induced physical dependence, recorded as convulsions. It is suggested that PHT through a chelate binding with Zn and Cu interferes with the metabolism of the trace elements and the drug may cause a Zn deficiency. The observed decrease of the brain weights may have some parallel to the mental side effects of the drug observed during chronic epilepsy therapy.</p>","PeriodicalId":77753,"journal":{"name":"Neurochemical pathology","volume":"5 2","pages":"87-106"},"PeriodicalIF":0.0000,"publicationDate":"1986-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03160125","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochemical pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03160125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

The effects of phenytoin (PHT) treatment on brain weights and the zinc (Zn) and copper (Cu) concentrations in liver, kidney, and five parts of the brain have been studied in rats. After 32 wk of treatment (daily doses 72-88 mg/kg body weight), significantly reduced brain weights were found in rats sacrificed during treatment, but not in those sacrificed after 14 d of abstinence. The weight reduction mainly seemed to affect cortex, but cerebellum was also influenced. The PHT treatment during 18 wk did not significantly reduce the brain weights. At the end of treatment, significantly increased serum Cu concentrations were found, as well as decreased Zn levels in the liver and low Cu levels in the kidney. No large alterations were found in the trace element concentrations of different brain regions. The PHT treatment for 32 wk induced physical dependence, recorded as convulsions. It is suggested that PHT through a chelate binding with Zn and Cu interferes with the metabolism of the trace elements and the drug may cause a Zn deficiency. The observed decrease of the brain weights may have some parallel to the mental side effects of the drug observed during chronic epilepsy therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长期苯妥英治疗对大鼠脑重及锌铜代谢的影响。
本文研究了苯妥英(PHT)对大鼠脑重量及肝、肾、脑5个部位锌、铜浓度的影响。治疗32周后(每日剂量72-88 mg/kg体重),治疗期间牺牲的大鼠脑重量明显减少,而禁欲14 d后牺牲的大鼠脑重量则没有明显减少。体重减轻似乎主要影响皮质,但小脑也受到影响。PHT治疗18周后,脑重量没有明显减少。治疗结束时,血清铜浓度显著升高,肝脏锌水平下降,肾脏铜水平低。不同脑区微量元素浓度未见明显变化。PHT治疗32周引起身体依赖,记录为惊厥。提示PHT通过与Zn和Cu的螯合作用干扰微量元素的代谢,可能引起锌缺乏症。观察到的脑重量下降可能与慢性癫痫治疗期间观察到的药物对精神的副作用有一定的相似之处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The mechanism of ischemia-induced brain cell injury. The membrane theory. Peroxidative damage to cell membranes following cerebral ischemia. A cause of ischemic brain injury? Phosphoinositide turnover and calcium ion mobilization in receptor activation. Polyamines in cerebral ischemia. Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1